National Advisory Council for Healthcare Research and Quality: Request for Nominations for Public Members, 29082-29083 [2017-13396]

Download as PDF 29082 Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices PERSON TO CONTACT FOR INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. Agency for Healthcare Research and Quality Dayna C. Brown, Secretary and Clerk of the Commission. National Advisory Council for Healthcare Research and Quality: Request for Nominations for Public Members [FR Doc. 2017–13545 Filed 6–23–17; 4:15 pm] BILLING CODE 6715–01–P FEDERAL RESERVE SYSTEM mstockstill on DSK30JT082PROD with NOTICES The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than July 24, 2017. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Bern Bancshares, Inc., Bern, Kansas; to acquire up to 6.47 percent of the voting shares of UBT Bancshares, Inc., and thereby indirectly acquire shares of United Bank & Trust, both in Marysville, Kansas. Board of Governors of the Federal Reserve System, June 22, 2017. Yao-Chin Chao, Assistant Secretary of the Board. BILLING CODE 6210–01–P VerDate Sep<11>2014 18:33 Jun 26, 2017 Jkt 241001 Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of request for nominations for public members. AGENCY: Formations of, Acquisitions by, and Mergers of Bank Holding Companies [FR Doc. 2017–13419 Filed 6–26–17; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES The Council advises the Secretary of HHS (Secretary) and the Director of the Agency for Healthcare Research and Quality (AHRQ) on matters related to activities of the Agency to carry out its mission. AHRQ’s mission is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work within the U.S. epartment of Health and Human Services and with other partners to make sure that the evidence is understood and used. Seven current members’ terms will expire in November 2017 DATES: Nominations should be received on or before 60 days after date of publication. SUMMARY: Nominations should be sent to Jaime Zimmerman AHRQ, 5600 Fishers Lane, 06E37A, Rockville, Maryland 20857. Nominations may also be emailed to NationalAdvisory Council@ahrq.hhs.gov. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, AHRQ, at (301) 427– 1456. SUPPLEMENTARY INFORMATION: 42 U.S.C. 299c establishes a National Advisory Council for Healthcare Research and Quality (the Council) and provides that the Secretary shall appoint to the National Advisory Council for Healthcare Research and Quality twenty one appropriately qualified individuals. At least seventeen members shall be representatives of the public and at least one member shall be a specialist in the rural aspects of one or more of the professions or fields listed in the above summary. In addition, the Secretary designates, as ex officio members, representatives from other Federal agencies, principally agencies that conduct or support health care research, as well as Federal officials the Secretary may consider appropriate. 42 U.S.C. 299c(c)(3). Consistent with revised guidance regarding the ban on lobbyists serving as members of advisory boards and commissions, AHRQ will accept nominations for Federally registered ADDRESSES: PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 lobbyists to serve on the Council in a representative capacity. The Council meets in the Washington, DC, metropolitan area, generally in Rockville, Maryland, approximately three times a year to provide broad guidance to the Secretary and AHRQ’s Director on the direction of and programs undertaken by AHRQ. Seven individuals will be selected by the Secretary to serve on the Council beginning with the meeting in the spring of 2018. Members generally serve 3-year terms. Appointments are staggered to permit an orderly rotation of membership. To fill these positions, we are seeking individuals with experience and success in (1) the conduct of research, demonstration projects, and evaluations with respect to health care; (2) the fields of health care quality research or health care improvement; (3) the practice of medicine; (4) other health professions; (5) representing the private health care sector (including health plans, providers, and purchasers) or administrators of health care delivery systems; (6) the fields of health care economics, information systems, law, ethics, business, or public policy; and, (7) representing the interests of patients and consumers of health care. Interested persons may nominate one or more qualified persons for membership on the Council. Selfnominations are accepted. Nominations shall include: (1) A copy of the nominee’s resume or curriculum vitae; and (2) a statement that the nominee is willing to serve as a member of the Council. Selected candidates will be asked to provide detailed information concerning their financial interests, consultant positions and research grants and contracts, to permit evaluation of possible sources of conflict of interest. Please note that once a candidate is nominated, AHRQ may consider that nomination for future positions on the Council. The Department seeks a broad geographic representation. In addition, AHRQ conducts and supports research concerning priority populations, which include: Low-income groups; minority groups; women; children; the elderly; and individuals with special health care needs, including individuals with disabilities and individuals who need chronic care or end-of-life health care. See 42 U.S.C. 299(c). Nominations of persons with expertise in health care for E:\FR\FM\27JNN1.SGM 27JNN1 Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices these priority populations are encouraged. Sharon B. Arnold, Deputy Director. [FR Doc. 2017–13396 Filed 6–26–17; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of public meeting. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Wednesday, July 26, 2017, from 8:30 a.m. to 2:45 p.m. ADDRESSES: The meeting will be held at AHRQ, 5600 Fishers Lane, Rockville, Maryland, 20857. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427– 1456. For press-related information, please contact Alison Hunt at (301) 427– 1244 or Alison.Hunt@ahrq.hhs.gov. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Wednesday, July 19, 2017. The agenda, roster, and minutes will be available from Ms. Bonnie Campbell, Committee Management Officer, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms. Campbell’s phone number is (301) 427–1554. SUPPLEMENTARY INFORMATION: SUMMARY: mstockstill on DSK30JT082PROD with NOTICES I. Purpose The National Advisory Council for Healthcare Research and Quality is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on VerDate Sep<11>2014 18:33 Jun 26, 2017 Jkt 241001 matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Wednesday, July 26, 2017, there will be a subcommittee meeting for the National Healthcare Quality and Disparities Report scheduled to begin at 7:30 a.m. This meeting is open to the public. The Council meeting will convene at 8:30 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting is open to the public and will be available via webcast at www.webconferences.com/ahrq. The meeting will begin with an update on AHRQ’s current research, programs, and initiatives. The agenda will also include an update on AHRQ’s work in learning health care systems and AHRQ’s EvidenceNOW initiative, and will focus on the use of AHRQ data and analytics to answer emerging policy questions. The final agenda will be available on the AHRQ Web site at www.AHRQ.gov no later than Wednesday, July 19, 2017. Sharon B. Arnold, Deputy Director. [FR Doc. 2017–13393 Filed 6–26–17; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Supplemental Evidence and Data Request on Drug Therapy for Early Rheumatoid Arthritis in Adults—An Update Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Request for supplemental evidence and data submissions. AGENCY: The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review of Drug Therapy for Early Rheumatoid Arthritis in Adults—An Update, which is currently being conducted by the SUMMARY: PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 29083 AHRQ’s Evidence-based Practice Centers (EPC) Program. Access to published and unpublished pertinent scientific information will improve the quality of this review. DATES: Submission Deadline on or before July 27, 2017. ADDRESSES: Email submissions: SEADS@epc-src.org. Print submissions: Mailing Address: Portland VA Research Foundation, Scientific Resource Center, ATTN: Scientific Information Packet Coordinator, P.O. Box 69539, Portland, OR 97239. Shipping Address (FedEx, UPS, etc.): Portland VA Research Foundation, Scientific Resource Center, ATTN: Scientific Information Packet Coordinator, 3710 SW U.S. Veterans Hospital Road, Mail Code: R&D 71, Portland, OR 97239. FOR FURTHER INFORMATION CONTACT: Ryan McKenna, Telephone: 503–220– 8262 ext. 51723 or Email: SEADS@epcsrc.org. SUPPLEMENTARY INFORMATION: AHRQ is conducting this systematic review pursuant to Section 902(a) of the Public Health Service Act, 42 U.S.C. 299a(a). The Agency for Healthcare Research and Quality has commissioned the Evidence-based Practice Centers (EPC) Program to complete a review of the evidence for Drug Therapy for Early Rheumatoid Arthritis in Adults—An Update. The EPC Program is dedicated to identifying as many studies as possible that are relevant to the questions for each of its reviews. In order to do so, we are supplementing the usual manual and electronic database searches of the literature by requesting information from the public (e.g., details of studies conducted). We are looking for studies that report on Drug Therapy for Early Rheumatoid Arthritis in Adults—An Update, including those that describe adverse events. The entire research protocol, including the key questions, is also available online at: https://effective healthcare.ahrq.gov/search-for-guidesreviews-and-reports/?pageaction= displayproduct&productID=2475. This is to notify the public that the EPC Program would find the following information on Drug Therapy for Early Rheumatoid Arthritis in Adults—An Update helpful: D A list of completed studies that your organization has sponsored for this indication. In the list, please indicate whether results are available on ClinicalTrials.gov along with the ClinicalTrials.gov trial number. D For completed studies that do not have results on ClinicalTrials.gov, E:\FR\FM\27JNN1.SGM 27JNN1

Agencies

[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Pages 29082-29083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13396]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


National Advisory Council for Healthcare Research and Quality: 
Request for Nominations for Public Members

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of request for nominations for public members.

-----------------------------------------------------------------------

SUMMARY: The Council advises the Secretary of HHS (Secretary) and the 
Director of the Agency for Healthcare Research and Quality (AHRQ) on 
matters related to activities of the Agency to carry out its mission. 
AHRQ's mission is to produce evidence to make health care safer, higher 
quality, more accessible, equitable, and affordable, and to work within 
the U.S. epartment of Health and Human Services and with other partners 
to make sure that the evidence is understood and used. Seven current 
members' terms will expire in November 2017

DATES: Nominations should be received on or before 60 days after date 
of publication.

ADDRESSES: Nominations should be sent to Jaime Zimmerman AHRQ, 5600 
Fishers Lane, 06E37A, Rockville, Maryland 20857. Nominations may also 
be emailed to NationalAdvisoryCouncil@ahrq.hhs.gov.

FOR FURTHER INFORMATION CONTACT:  Jaime Zimmerman, AHRQ, at (301) 427-
1456.

SUPPLEMENTARY INFORMATION: 42 U.S.C. 299c establishes a National 
Advisory Council for Healthcare Research and Quality (the Council) and 
provides that the Secretary shall appoint to the National Advisory 
Council for Healthcare Research and Quality twenty one appropriately 
qualified individuals. At least seventeen members shall be 
representatives of the public and at least one member shall be a 
specialist in the rural aspects of one or more of the professions or 
fields listed in the above summary. In addition, the Secretary 
designates, as ex officio members, representatives from other Federal 
agencies, principally agencies that conduct or support health care 
research, as well as Federal officials the Secretary may consider 
appropriate. 42 U.S.C. 299c(c)(3). Consistent with revised guidance 
regarding the ban on lobbyists serving as members of advisory boards 
and commissions, AHRQ will accept nominations for Federally registered 
lobbyists to serve on the Council in a representative capacity.
    The Council meets in the Washington, DC, metropolitan area, 
generally in Rockville, Maryland, approximately three times a year to 
provide broad guidance to the Secretary and AHRQ's Director on the 
direction of and programs undertaken by AHRQ.
    Seven individuals will be selected by the Secretary to serve on the 
Council beginning with the meeting in the spring of 2018. Members 
generally serve 3-year terms. Appointments are staggered to permit an 
orderly rotation of membership. To fill these positions, we are seeking 
individuals with experience and success in (1) the conduct of research, 
demonstration projects, and evaluations with respect to health care; 
(2) the fields of health care quality research or health care 
improvement; (3) the practice of medicine; (4) other health 
professions; (5) representing the private health care sector (including 
health plans, providers, and purchasers) or administrators of health 
care delivery systems; (6) the fields of health care economics, 
information systems, law, ethics, business, or public policy; and, (7) 
representing the interests of patients and consumers of health care.
    Interested persons may nominate one or more qualified persons for 
membership on the Council. Self-nominations are accepted. Nominations 
shall include: (1) A copy of the nominee's resume or curriculum vitae; 
and (2) a statement that the nominee is willing to serve as a member of 
the Council. Selected candidates will be asked to provide detailed 
information concerning their financial interests, consultant positions 
and research grants and contracts, to permit evaluation of possible 
sources of conflict of interest. Please note that once a candidate is 
nominated, AHRQ may consider that nomination for future positions on 
the Council.
    The Department seeks a broad geographic representation. In 
addition, AHRQ conducts and supports research concerning priority 
populations, which include: Low-income groups; minority groups; women; 
children; the elderly; and individuals with special health care needs, 
including individuals with disabilities and individuals who need 
chronic care or end-of-life health care. See 42 U.S.C. 299(c). 
Nominations of persons with expertise in health care for

[[Page 29083]]

these priority populations are encouraged.

Sharon B. Arnold,
Deputy Director.
[FR Doc. 2017-13396 Filed 6-26-17; 8:45 am]
 BILLING CODE 4160-90-P